TTN Gene Myopathy Early-Onset with Fatal Cardiomyopathy Genetic Test sale cost 4400 AED
SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test sale cost 4400 AED SLC5A7 Gene Myasthenic Syndrome Congenital Type 20 Presynaptic Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MTM1 Gene Myotubular Myopathy X-Linked Genetic Test sale cost 4400 AED MTM1 Gene Myotubular Myopathy X-Linked Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

TTN Gene Myopathy Early-Onset with Fatal Cardiomyopathy Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “TTN Gene Myopathy Early-Onset with Fatal Cardiomyopathy Genetic Test” is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TTN gene. These mutations are associated with early-onset myopathy, a condition characterized by muscle weakness and wasting, which can lead to severe, often fatal, cardiomyopathy – a disease of the heart muscle that makes it harder for the heart to pump blood to the rest of the body.

This genetic test is crucial for individuals who exhibit symptoms of myopathy or have a family history of cardiomyopathy, as early detection can significantly influence management and treatment options. The test involves analyzing the patient’s DNA to look for specific genetic alterations in the TTN gene, which is known to play a vital role in muscle function and structure.

Priced at 4400 AED, the test is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. By opting for this test, patients and their families can gain valuable insights into their genetic predisposition to these conditions, enabling them to make informed decisions regarding their health and future.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TTN Gene Myopathy early-onset with fatal cardiomyopathy Genetic Test

Cost: AED 4400.0

Test Components:

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for TTN Gene Myopathy, early-onset with fatal cardiomyopathy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TTN Gene Myopathy, early-onset with fatal cardiomyopathy.

Test Details

TTN gene myopathy, early-onset with fatal cardiomyopathy is a genetic disorder that affects the TTN gene. This gene provides instructions for making a protein called titin, which is important for the structure and function of muscle cells, particularly in the heart.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TTN gene myopathy, NGS genetic testing can identify any mutations or variations in the TTN gene that may be causing the disorder.

Early-onset with fatal cardiomyopathy refers to the fact that this condition typically manifests early in life and is characterized by the development of severe heart muscle weakness (cardiomyopathy) that can be life-threatening.

The symptoms of TTN gene myopathy can vary but often include muscle weakness, difficulty breathing, fatigue, and heart problems.

NGS genetic testing for TTN gene myopathy, early-onset with fatal cardiomyopathy can help with the diagnosis of the condition, as well as provide information about the specific genetic mutations involved. This information can be valuable for understanding the underlying cause of the disorder, predicting disease progression, and potentially informing treatment decisions.

Test Name TTN Gene Myopathy early-onset with fatal cardiomyopathy Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TTN Gene Myopathy, early-onset with fatal cardiomyopathy NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TTN Gene Myopathy, early-onset with fatal cardiomyopathy
Test Details

TTN gene myopathy, early-onset with fatal cardiomyopathy is a genetic disorder that affects the TTN gene. This gene provides instructions for making a protein called titin, which is important for the structure and function of muscle cells, particularly in the heart.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TTN gene myopathy, NGS genetic testing can identify any mutations or variations in the TTN gene that may be causing the disorder.

Early-onset with fatal cardiomyopathy refers to the fact that this condition typically manifests early in life and is characterized by the development of severe heart muscle weakness (cardiomyopathy) that can be life-threatening. The symptoms of TTN gene myopathy can vary but often include muscle weakness, difficulty breathing, fatigue, and heart problems.

NGS genetic testing for TTN gene myopathy, early-onset with fatal cardiomyopathy can help with the diagnosis of the condition, as well as provide information about the specific genetic mutations involved. This information can be valuable for understanding the underlying cause of the disorder, predicting disease progression, and potentially informing treatment decisions.

SKU: TEST-1800 Category:

Related products